key: cord-0702961-yg613ny7
authors: Rani, Pallavali R.; Imran, Mohamed; Lakshmi, Juturu V.; Jolly, Bani; Jain, Abhinav; Surekha, Avileli; Senthivel, Vigneshwar; Chandrasekhar, Pulala; Divakar, Mohit K.; Srinivasulu, Damam; Bhoyar, Rahul C.; Vanaja, P. R.; Scaria, Vinod; Sivasubbu, Sridhar
title: Symptomatic reinfection of SARS‐CoV‐2 with spike protein variant N440K associated with immune escape
date: 2021-04-13
journal: J Med Virol
DOI: 10.1002/jmv.26997
sha: 0f94ebe5ca4a3d2fd3a1b79be980a8ed31f0ec95
doc_id: 702961
cord_uid: yg613ny7

This report describes a case of re-infection in an individual from South India characterized by whole genome sequencing of the virus isolated from both episodes. The analysis shows the presence of an immune escape variant N440K in the Spike protein in both episodes of infection. Incidentally, this variant was also found in a case of reinfection previously reported by us in a healthcare worker from North India This article is protected by copyright. All rights reserved.

Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape Dear Editor, A number of cases of reinfections in individuals with SARS-CoV-2 have emerged across the globe. 1, 2 With the emergence of genetic variants associated with immune escape in many regions of the world, it is being widely believed that immune escape variants could contribute to an increase in reinfections as well as potentially adversely affect the efficacy of vaccines. 3, 4 A recent report also describes reinfection in a patient with neutralizing antibodies and identified an immune escape variant in the spike protein. 5 Here, we describe a case of reinfection in an individual from South India characterized by whole genome sequencing of the virus isolated from both episodes. Analysis shows the presence of an immune escape variant N440K in the Spike protein in both episodes of infection.

Incidentally, this variant was also found in a case of reinfection previously reported by us by a healthcare worker from North India. 1 In the first episode of infection, the 47-year-old male civil official from Andhra Pradesh, India, was identified to be positive for SARS-CoV-2 on July 25, 2020, in nasopharyngeal specimens analyzed as a part of routine surveillance and was asymptomatic. The cycle threshold values (C t ) were 22.3 and 19.1 for ORF1ab and N genes, respectively (Labsystems Diagnostic Inc.). The individual tested negative on August 2, 2020, and tested positive again on September 10, 2020, during routine surveillance, but during this episode, he was symptomatic with fever, cough, and malaise. The C t values for the probes targeting ORF1ab and N genes were 21.9 and 19.2, respectively (Labsystems Diagnostic Inc.) during this episode and he tested negative after 14 days.

The RNA samples were sequenced using COVIDSeq protocol 6 on Illumina MiSeq (Illumina Inc) generating paired-end sequencing (75 × 2 bp) reads, which were analysed as per standard protocols. 7 Variants were called using VarScan. 8 Only variants having a frequency greater than 50% and a minimum depth of 50 reads were considered for further analysis. Lineages were assigned using PANGOLIN. 9 The analysis revealed a total of 15 and 17 genetic variants in the genomes from the two episodes E1 and E2, respectively, of which 14 variants were common between the two episodes ( 

The authors declare that there are no conflict of interests. 

All sequences generated in this study have been submitted to GISAID (accession IDs EPI_ISL_1103556 and EPI_ISL_1103557). 

Asymptomatic reinfection in 2 healthcare workers from india with genetically distinct severe acute respiratory syndrome coronavirus 2

COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

Genomic evidence of a SARS-CoV-2 reinfection case with E484K spike mutation in Brazil

High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq nextgeneration sequencing

Computational Protocol for Assembly and Analysis of SARS-nCoV-2 Genomes Res Rep

VarScan: variant detection in massively parallel sequencing of individual and pooled samples

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

SARS-CoV-2 reinfection by the new Variant of Concern (VOC) P.1 in Amazonas, Brazil

Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil

Centers for Disease Control and Prevention. Emerging SARS-CoV-2 Variants. 2021

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies. medRxiv